Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 606-970-7 | CAS number: 222716-77-0
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics, other
- Type of information:
- other: expert statement
- Adequacy of study:
- supporting study
- Executive summary:
No specific study was performed on the absorption, distribution, metabolism and/or excretion (ADME) of WS400506. Predictions on toxico-kinetics were based on physical-chemical properties and results of toxicological studies.
The UVCB substance consists of esters of various fatty acids (primarily C18 from tall oil) and 4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane. The molecular weight of the esters amounts to approx. 900 Da. Water solubility is very low, < 1 mg/l. The water/octanol partition coefficient was determined to amount to amount to log Pow > 6. Determination of the vapour pressure resulted in a value of 0.0004 Pa.
The physico-chemical and toxicological information on the substance has been used to assess its toxicokinetic behaviour according to the ECHA “Guidance on information requirements and chemical safety assessment Chapter R.7c: Endpoint specific guidance”.
Dermal absorption
The low water solubility and high lipophilicity (log Pow > 6) together with the high molecular weight of the constituents of WS400506 will limit absorption across the skin. No dermal or eye irritation was observed.
Oral absorption
The low water solubility and high lipophilicity (log Pow > 6) together with the high molecular weight of the constituents of WS400506 will limit absorption in the digestive tract. However, after repeated dosing of rats with high levels of WS400506 (>= 300 mg/kg/day) intestinal changes were observed in mesenteric lymph nodes and in the small intestines (not being associated with any inflammatory or degenerative changes). This indicates that some absorption via oral exposure is possible.
Respiratory absorption
WS400506 is a waxy solid and has a very low vapour pressure. It decomposes before boiling. Accordingly, inhalation is an unlikely route of human exposure.
Distribution, metabolism, and excretion
There is no information available on distribution, metabolism, and excretion of WS400506 in the available studies.
Based on the available data the bioacumulation potential cannot be judged. However, based on the favourable testing results, i.e. low toxicological potential, on the one hand and on the very low dermal and inhalative bioavailability of the substance (due to its physical-chemical properties) on the other hand there is no need for further investigations of a bioaccumulation potential.
Reference
Description of key information
Key value for chemical safety assessment
Additional information
No specific study was performed on the absorption, distribution, metabolism and/or excretion (ADME) of WS400506. Predictions on toxico-kinetics were based on physical-chemical properties and results of toxicological studies.
The UVCB substance consists of esters of various fatty acids (primarily C18 from tall oil) and 4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane. The molecular weight of the esters amounts to approx. 900 Da. Water solubility is very low, < 1 mg/l. The water/octanol partition coefficient was determined to amount to amount to log Pow > 6. Determination of the vapour pressure resulted in a value of 0.0004 Pa.
The physico-chemical and toxicological information on the substance has been used to assess its toxicokinetic behaviour according to the ECHA “Guidance on information requirements and chemical safety assessment Chapter R.7c: Endpoint specific guidance”.
Dermal absorption
The low water solubility and high lipophilicity (log Pow > 6) together with the high molecular weight of the constituents of WS400506 will limit absorption across the skin. No dermal or eye irritation was observed.
Oral absorption
The low water solubility and high lipophilicity (log Pow > 6) together with the high molecular weight of the constituents of WS400506 will limit absorption in the digestive tract. However, after repeated dosing of rats with high levels of WS400506 (>= 300 mg/kg/day) intestinal changes were observed in mesenteric lymph nodes and in the small intestines (not being associated with any inflammatory or degenerative changes). This indicates that some absorption via oral exposure is possible.
Respiratory absorption
WS400506 is a waxy solid and has a very low vapour pressure. It decomposes before boiling. Accordingly, inhalation is an unlikely route of human exposure.
Distribution, metabolism, and excretion
There is no information available on distribution, metabolism, and excretion of WS400506 in the available studies.
Based on the available data the bioacumulation potential cannot be judged. However, based on the favourable testing results, i.e. low toxicological potential, on the one hand and on the very low dermal and inhalative bioavailability of the substance (due to its physical-chemical properties) on the other hand there is no need for further investigations of a bioaccumulation potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
